[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2014DN10683A - - Google Patents

Info

Publication number
IN2014DN10683A
IN2014DN10683A IN10683DEN2014A IN2014DN10683A IN 2014DN10683 A IN2014DN10683 A IN 2014DN10683A IN 10683DEN2014 A IN10683DEN2014 A IN 10683DEN2014A IN 2014DN10683 A IN2014DN10683 A IN 2014DN10683A
Authority
IN
India
Prior art keywords
dopyridine
benzylcarbami
prevention
methyl
compound
Prior art date
Application number
Inventor
Filya Zhebrovska
Grygorii Kostiuk
Mykhailo Vanat
Viktor Margitych
Original Assignee
Farmak Internat Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmak Internat Holding Gmbh filed Critical Farmak Internat Holding Gmbh
Publication of IN2014DN10683A publication Critical patent/IN2014DN10683A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present application relates to a new salt of N-methyl-4-benzylcarbami- dopyridine, a process for its preparation, a pharmaceutical composition comprising this compound and its use for the treatment or prevention of viral diseases.
IN10683DEN2014 2012-05-18 2013-05-16 IN2014DN10683A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2012/059258 WO2013170901A1 (en) 2012-05-18 2012-05-18 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
PCT/EP2013/060158 WO2013171307A1 (en) 2012-05-18 2013-05-16 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation

Publications (1)

Publication Number Publication Date
IN2014DN10683A true IN2014DN10683A (en) 2015-08-28

Family

ID=48483057

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10683DEN2014 IN2014DN10683A (en) 2012-05-18 2013-05-16

Country Status (12)

Country Link
US (2) US9493416B2 (en)
EP (1) EP2850063B1 (en)
JP (1) JP2015517513A (en)
KR (1) KR101777561B1 (en)
BR (1) BR112014028576B1 (en)
CA (1) CA2873977C (en)
EA (1) EA025409B1 (en)
ES (1) ES2573286T3 (en)
IN (1) IN2014DN10683A (en)
PL (1) PL2850063T3 (en)
UA (1) UA110889C2 (en)
WO (2) WO2013170901A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2689775C1 (en) * 2018-11-02 2019-05-29 Открытое акционерное общество "Авексима" Industrial production of n-methyl-4-benzylcarbamidopyridinium iodide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU58612A1 (en) 1939-10-29 1939-11-30 П.С. Мордовин Device for connecting two-subscriber devices to one station line
SU548612A1 (en) 1975-07-18 1977-02-28 Казанский Химико-Технологический Институт Им.С.М.Кирова Method for preparing 10-chlorophenoxarsine
US4115390A (en) * 1977-08-19 1978-09-19 Nardi John C Method for the preparation of 1-alkyl pyridinium chlorides
ATE194983T1 (en) * 1992-06-04 2000-08-15 Micro Flo Co MEPIQUATCHLORIDE COVERED WITH A WATER SOLUBLE POLYMER
WO2011158058A1 (en) 2010-06-17 2011-12-22 Farmak International Holding Gmbh α-CRYSTALLINE FORM OF CARBABENZPYRIDE

Also Published As

Publication number Publication date
UA110889C2 (en) 2016-02-25
WO2013171307A1 (en) 2013-11-21
US20170037011A1 (en) 2017-02-09
KR20150013124A (en) 2015-02-04
BR112014028576A2 (en) 2017-06-27
EP2850063A1 (en) 2015-03-25
EA025409B1 (en) 2016-12-30
BR112014028576B1 (en) 2020-11-03
EP2850063B1 (en) 2016-04-13
US20140357677A1 (en) 2014-12-04
ES2573286T3 (en) 2016-06-07
CN104321312A (en) 2015-01-28
KR101777561B1 (en) 2017-09-12
PL2850063T3 (en) 2016-10-31
US9493416B2 (en) 2016-11-15
CA2873977A1 (en) 2013-11-21
JP2015517513A (en) 2015-06-22
EA201492161A1 (en) 2015-03-31
CA2873977C (en) 2019-09-17
WO2013170901A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
GB201118656D0 (en) New compounds
MX349004B (en) New compounds.
GB201209613D0 (en) New compounds
TN2015000278A1 (en) Autotaxin inhibitors
PH12014501702A1 (en) Imidazopyrrolidinone compounds
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MD4589B1 (en) Pharmaceutical composition comprising sofosbuvir and uses thereof for treating hepatitis C virus
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MX366899B (en) New compounds.
MX355267B (en) 2'- substituted carba-nucleoside analogs for antiviral treatment.
IN2014MN00986A (en)
MX2013012053A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
ZA201308617B (en) Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
MX2015007916A (en) Peri-carbinols.
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
MX2015003034A (en) Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same.
NZ707773A (en) Methods of treating liver diseases
IN2014DN03010A (en)
IN2013MU03118A (en)
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
IN2014DN10683A (en)
PH12015502703A1 (en) Pharmaceutical compositions
IN2014DN07897A (en)
MX2013002446A (en) Substituted tetrahydropyrrolopyrazine derivatives.